AceLink is advancing a small-molecule treatment option for Fabry disease, which could provide a more convenient alternative ...
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback